Related Experiment Video
Updated: Jul 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Frailty in Pulmonary Arterial Hypertension: A Cohort Study
Gordon J Farley1, Melanie Prakash2, Harold I Palevsky2
1Department of Internal Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.
Rationale:
Frailty is associated with increased morbidity and mortality. Patients with pulmonary arterial hypertension (PAH) are at a high risk of frailty; however, frailty has been understudied in PAH.
Objectives:
Understand the risk factors for and determine the impact of frailty on quality of life (QoL) and mortality in patients with PAH.
Methods:
A prospective single center cohort enrolled 80 patients with PAH. Demographic, metabolic, hemodynamic, and QoL data were collected, and frailty was assessed via the Short Physical Performance Battery (SPPB) at baseline, 6-months and 12-months. Frailty or pre-frailty was defined as an SPPB score of ≤ 9.
Measurements And Main Results:
In this cohort of patients with PAH, 49% were frail. Mean age was 57.6 years, 82.5% were female, and idiopathic (33.8%) and connective tissue disease associated (32.5%) PAH were the most common etiologies. Compared to non-frail patients, frail participants were significantly older, had greater mortality risk, and had significantly increased fat mass index, android-to-gynoid ratio, and visceral adipose tissue area. Higher levels of IL-6 were significantly associated with odds of frailty, although IL-6 did not mediate the association of body fat on frailty. Frail patients had worse QoL and worse transplant-free survival compared to non-frail patients. The percentage of patients with frailty increased over 1 year from 54.2% to 64.4%.
Conclusions:
Frailty was prevalent in this cohort of patients with PAH and was associated with older age, higher risk for mortality and body fat. Frailty in patients with PAH was associated with worse QoL and worse survival.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

